FERTIBERIA, S.A. – Trademark Portfolio
Entity Type: 98
FERTIBERIA, S.A. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 18 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 16 trademarks are registered. Notable registered marks include NEOFORCE, NEOFORCE CARE, FERTIBERIA TECH, NEOFORCE ANTIOX, and NEOFORCE RANGER.
Calle Agustín de Foxá, 27 Plantas 8-11
E-28036 Madrid
Showing of trademarks Trademarks
Trademark Classifications
FERTIBERIA, S.A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does FERTIBERIA, S.A. have?
FERTIBERIA, S.A. has 18 U.S. trademarks filed with the USPTO. Of these, 16 registered, 2 abandoned.
What trademark classes does FERTIBERIA, S.A. file in?
FERTIBERIA, S.A. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are FERTIBERIA, S.A.'s most well-known trademarks?
FERTIBERIA, S.A.'s registered trademark portfolio includes well-known marks such as NEOFORCE, NEOFORCE CARE, FERTIBERIA TECH, NEOFORCE ANTIOX, and NEOFORCE RANGER. These are among 16 currently registered trademarks in the portfolio.
What is FERTIBERIA, S.A.'s trademark registration success rate?
FERTIBERIA, S.A. has a 89% trademark registration rate, with 16 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.